P. D. Hughes, Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity, Immunity, vol.28, pp.197-205, 2008.

J. Hutcheson, Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity, Immunity, vol.28, pp.206-217, 2008.

A. E. Weant, Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction, Immunity, vol.28, pp.218-230, 2008.

L. A. O'reilly, Membrane-bound Fas ligand only is essential for Fas-induced apoptosis, Nature, vol.461, pp.659-663, 2009.

L. Chen, CD95 promotes tumour growth, Nature, vol.465, pp.492-496, 2010.

M. E. Peter, The CD95 receptor: apoptosis revisited, Cell, vol.129, pp.447-450, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00318978

M. E. Peter, The role of CD95 and CD95 ligand in cancer, Cell Death Differ, vol.22, pp.549-559, 2015.

A. Fouque, L. Debure, and P. Legembre, The CD95/CD95L signaling pathway: a role in carcinogenesis, Biochim Biophys Acta, vol.1846, pp.130-141, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01061290

A. Poissonnier, CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice, Immunity, vol.45, pp.209-223, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01359568

K. Chakrabandhu, S. Huault, and A. O. Hueber, Distinctive molecular signaling in triple-negative breast cancer cell death triggered by hexadecylphosphocholine (miltefosine), FEBS Lett, vol.582, pp.4176-4184, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00349454

K. Chakrabandhu and A. O. Hueber, Fas Versatile Signaling and Beyond: Pivotal Role of Tyrosine Phosphorylation in Context-Dependent Signaling and Diseases, SCIeNTIFIC REpORTs |, vol.8, p.429, 2016.

W. Wick, A phase II, randomized, study of weekly APG101 + reirradiation versus reirradiation in progressive glioblastoma, Clin Cancer Res, vol.20, pp.6304-6313, 2014.

K. Chakrabandhu, An Evolution-Guided Analysis Reveals a Multi-Signaling Regulation of Fas by Tyrosine Phosphorylation and its Implication in Human Cancers, PLoS Biol, vol.14, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01438523

T. Troiani, Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence, ESMO Open, vol.1, p.88, 2016.

C. R. Chong and P. A. Janne, The quest to overcome resistance to EGFR-targeted therapies in cancer, Nat Med, vol.19, pp.1389-1400, 2013.

S. Kleber, Yes and PI3K bind CD95 to signal invasion of glioblastoma, Cancer Cell, vol.13, pp.235-248, 2008.

A. Citri and Y. Yarden, EGF-ERBB signalling: towards the systems level, Nat Rev Mol Cell Biol, vol.7, pp.505-516, 2006.

M. A. Lemmon, J. Schlessinger, and K. M. Ferguson, The EGFR family: not so prototypical receptor tyrosine kinases, Cold Spring Harb Perspect Biol, vol.6, p.20768, 2014.

H. H. Lee, Y. N. Wang, and M. C. Hung, Non-canonical signaling mode of the epidermal growth factor receptor family, Am J Cancer Res, vol.5, pp.2944-2958, 2015.

T. G. Bivona, FAS and NF-kappaB signalling modulate dependence of lung cancers on mutant EGFR, Nature, vol.471, pp.523-526, 2011.

H. W. Lo, Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer, Cancer Res, vol.65, pp.338-348, 2005.

A. Psyrri, Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarray, Cancer Epidemiol Biomarkers Prev, vol.17, pp.1486-1492, 2008.

Y. N. Wang and M. C. Hung, Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family, Cell Biosci, vol.2, p.13, 2012.

M. Malleter, CD95L cell surface cleavage triggers a prometastatic signaling pathway in triple-negative breast cancer, Cancer Res, vol.73, pp.6711-6721, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00873634

S. J. Parsons and J. T. Parsons, Src family kinases, key regulators of signal transduction, Oncogene, vol.23, pp.7906-7909, 2004.

C. M. Silva, Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis, Oncogene, vol.23, pp.8017-8023, 2004.

M. Iida, T. M. Brand, D. A. Campbell, C. Li, and D. L. Wheeler, Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor, Oncogene, vol.32, pp.759-767, 2013.

Y. Xu, Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells, J Exp Clin Cancer Res, vol.32, p.90, 2013.

S. Y. Lin, Nuclear localization of EGF receptor and its potential new role as a transcription factor, Nat Cell Biol, vol.3, pp.802-808, 2001.

R. Reinehr and D. Häussinger, Hyperosmotic activation of the CD95 system, Methods Enzymol, vol.428, issue.07, pp.28008-28013, 2007.

R. Reinehr, A. Sommerfeld, and D. Häussinger, CD95 ligand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells, Gastroenterology, vol.134, pp.1494-1506, 2008.

H. Masuda, Role of epidermal growth factor receptor in breast cancer, Breast Cancer Res Treat, vol.136, pp.331-345, 2012.

E. Teplinsky and F. Muggia, EGFR and HER2: is there a role in ovarian cancer?, Translational Cancer Research, vol.4, pp.107-117, 2015.

R. Dienstmann, R. Salazar, and J. Tabernero, Overcoming Resistance to Anti-EGFR Therapy in Colorectal Cancer, Am Soc Clin Oncol Educ Book, vol.56, pp.149-156, 2015.

F. Ciardiello and G. Tortora, EGFR antagonists in cancer treatment, N Engl J Med, vol.358, pp.1160-1174, 2008.

C. S. Karapetis, K-ras mutations and benefit from cetuximab in advanced colorectal cancer, N Engl J Med, vol.359, pp.1757-1765, 2008.

R. G. Amado, Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer, J Clin Oncol, vol.26, pp.1626-1634, 2008.

S. Misale, Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer, Nature, vol.486, pp.532-536, 2012.

L. A. Diaz, The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers, Nature, vol.486, pp.537-540, 2012.

H. Shao, H. Y. Cheng, R. G. Cook, and D. J. Tweardy, Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor, Cancer Res, vol.63, pp.3923-3930, 2003.

N. Ariotti, Epidermal growth factor receptor activation remodels the plasma membrane lipid environment to induce nanocluster formation, Mol Cell Biol, vol.30, pp.3795-3804, 2010.

S. M. Thomas and J. S. Brugge, Cellular functions regulated by Src family kinases, Annu Rev Cell Dev Biol, vol.13, pp.513-609, 1997.

R. Reinehr, S. Becker, A. Höngen, and D. Haüssinger, The Src family kinase Yes triggers hyperosmotic activation of the epidermal growth factor receptor and CD95, J Biol Chem, vol.279, pp.23977-23987, 2004.

C. Li, M. Iida, E. F. Dunn, A. J. Ghia, and D. L. Wheeler, Nuclear EGFR contributes to acquired resistance to cetuximab, Oncogene, vol.28, pp.3801-3813, 2009.

J. Zhang, L. L. Zhang, L. Shen, X. M. Xu, and H. G. Yu, Regulation of AKT gene expression by cisplatin, Oncol Lett, vol.5, pp.756-760, 2013.

M. Kuroki and J. T. O'flaherty, Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines, Biochem J, vol.341, pp.691-696, 1999.

Z. L. Chelsky, A Resveratrol Analogue Promotes ERKMAPK-Dependent Stat3 Serine and Tyrosine Phosphorylation Alterations and Antitumor Effects In Vitro against Human Tumor Cells, Mol Pharmacol, vol.88, pp.524-533, 2015.

J. Schindelin, Fiji: an open-source platform for biological-image analysis, Nat Meth, vol.9, pp.676-682, 2012.

K. Chakrabandhu, S. Huault, and A. O. Hueber, Site-Specific Detection of Tyrosine Phosphorylated CD95 Following Protein Separation by Conventional and Phospho-Protein Affinity SDS-PAGE, Methods Mol Biol, vol.1557, pp.173-188, 2017.

A. Nabbi and K. Riabowol, Rapid Isolation of Nuclei from CellsIn Vitro, Cold Spring Harb Protoc, pp.769-772, 2015.

A. T. Bida, D. Gil, and A. G. Schrum, Multiplex IP-FCM (immunoprecipitation-flow cytometry): Principles and guidelines for assessing physiologic protein-protein interactions in multiprotein complexes, Methods, vol.56, pp.154-160, 2012.